|
1
|
Bedford L, Lowe J, Dick LR, Mayer RJ and
Brownell JE: Ubiquitin-like protein conjugation and the
ubiquitin-proteasome system as drug targets. Nat Rev Drug Discov.
10:29–46. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
O'Connor HF and Huibregtse JM:
Enzyme-substrate relationships in the ubiquitin system: Approaches
for identifying substrates of ubiquitin ligases. Cell Mol Life Sci.
74:3363–3375. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Petroski MD and Deshaies RJ: Function and
regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol.
6:9–20. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Deshaies RJ, Emberley ED and Saha A:
Control of cullin-ring ubiquitin ligase activity by nedd8. Subcell
Biochem. 54:41–56. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ying J, Zhang M, Qiu X and Lu Y: Targeting
the neddylation pathway in cells as a potential therapeutic
approach for diseases. Cancer Chemother Pharmacol. 81:797–808.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xirodimas DP: Novel substrates and
functions for the ubiquitin-like molecule NEDD8. Biochem Soc Trans.
36:802–806. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zuo W, Huang F, Chiang YJ, Li M, Du J,
Ding Y, Zhang T, Lee HW, Jeong LS, Chen Y, et al: C-Cbl-mediated
neddylation antagonizes ubiquitination and degradation of the TGF-β
type II receptor. Mol Cell. 49:499–510. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao Y, Morgan MA and Sun Y: Targeting
neddylation pathways to inactivate cullin-RING ligases for
anticancer therapy. Antioxid Redox Signal. 21:2383–2400. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Watson IR, Irwin MS and Ohh M: NEDD8
pathways in cancer, sine quibus non. Cancer Cell. 19:168–176. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang DT, Ayrault O, Hunt HW, Taherbhoy
AM, Duda DM, Scott DC, Borg LA, Neale G, Murray PJ, Roussel MF and
Schulman BA: E2-RING expansion of the NEDD8 cascade confers
specificity to cullin modification. Mol Cell. 33:483–495. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cukras S, Morffy N, Ohn T and Kee Y:
Inactivating UBE2M impacts the DNA damage response and genome
integrity involving multiple cullin ligases. PLoS One.
9:e1018442014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu B, Deng Y, Bi R, Guo H, Shu C, Shah NK,
Chang J, Liu G, Du Y, Wei W and Wang C: A first-in-class inhibitor,
MLN4924 (pevonedistat), induces cell-cycle arrest, senescence, and
apoptosis in human renal cell carcinoma by suppressing
UBE2M-dependent neddylation modification. Cancer Chemother
Pharmacol. 81:1083–1093. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou W, Xu J, Tan M, Li H, Li H, Wei W and
Sun Y: UBE2M is a stress-inducible dual E2 for neddylation and
ubiquitylation that promotes targeted degradation of UBE2F. Mol
Cell. 70:1008–1024. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gao Q, Yu GY, Shi JY, Li LH, Zhang WJ,
Wang ZC, Yang LX, Duan M, Zhao H, Wang XY, et al: Neddylation
pathway is up-regulated in human intrahepatic cholangiocarcinoma
and serves as a potential therapeutic target. Oncotarget.
5:7820–7832. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Altekruse SF, Devesa SS, Dickie LA,
McGlynn KA and Kleiner DE: Histological classification of liver and
intrahepatic bile duct cancers in SEER registries. J Registry
Manag. 38:201–205. 2011.PubMed/NCBI
|
|
16
|
Bertuccio P, Bosetti C, Levi F, Decarli A,
Negri E and La Vecchia C: A comparison of trends in mortality from
primary liver cancer and intrahepatic cholangiocarcinoma in Europe.
Ann Oncol. 24:1667–1674. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bridgewater J, Galle PR, Khan SA, Llovet
JM, Park JW, Patel T, Pawlik TM and Gores GJ: Guidelines for the
diagnosis and management of intrahepatic cholangiocarcinoma. J
Hepatol. 60:1268–1289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Poultsides GA, Zhu AX, Choti MA and Pawlik
TM: Intrahepatic cholangiocarcinoma. Surg Clin North Am.
90:817–837. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Andersen JB, Spee B, Blechacz BR, Avital
I, Komuta M, Barbour A, Conner EA, Gillen MC, Roskams T, Roberts
LR, et al: Genomic and genetic characterization of
cholangiocarcinoma identifies therapeutic targets for tyrosine
kinase inhibitors. Gastroenterology. 14:1021–1031. 2012. View Article : Google Scholar
|
|
21
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-update. Nucleic Acids Res. 41:D991–D995. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Szklarczyk D, Gable AL, Lyon D, Junge A,
Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork
P, et al: STRING v11: Protein-protein association networks with
increased coverage, supporting functional discovery in genome-wide
experimental datasets. Nucleic Acids Res. 47:D607–D613. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li L, Kang J, Zhang W, Cai L, Wang S,
Liang Y, Jiang Y, Liu X, Zhang Y, Ruan H, et al: Validation of
NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung
cancer. EBioMedicine. 45:81–91. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brown JS, Lukashchuk N, Sczaniecka-Clift
M, Britton S, le Sage C, Calsou P, Calsou P, Beli P, Galanty Y and
Jackson SP: Neddylation promotes ubiquitylation and release of ku
from DNA-damage sites. Cell Rep. 11:704–714. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jimeno S, Fernandez-Avila MJ, Cruz-Garcia
A, Cepeda-Garcia C, Gomez-Cabello D and Huertas P: Neddylation
inhibits CtIP-mediated resection and regulates DNA double strand
break repair pathway choice. Nucleic Acids Res. 43:987–999. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mavros MN, Economopoulos KP, Alexiou VG
and Pawlik TM: Treatment and prognosis for patients with
intrahepatic cholangiocarcinoma: Systematic review and
meta-analysis. JAMA Surg. 149:565–574. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li L, Wang M, Yu G, Chen P, Li H, Wei D,
Zhu J, Xie L, Jia H, Shi J, et al: Overactivated neddylation
pathway as a therapeutic target in lung cancer. J Natl Cancer Inst.
106:dju0832014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang W, Liu Z, Qu P, Zhou Z, Zeng Y, Fan
J, Liu Y, Guo Y and Qiu J: Knockdown of regulator of cullins-1
(ROC1) expression induces bladder cancer cell cycle arrest at the
G2 phase and senescence. PLoS One. 8:e627342013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lan H, Tang Z, Jin H and Sun Y:
Neddylation inhibitor MLN4924 suppresses growth and migration of
human gastric cancer cells. Sci Rep. 6:242182016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wen M, Kwon Y, Wang Y, Mao JH and Wei G:
Elevated expression of UBE2T exhibits oncogenic properties in human
prostate cancer. Oncotarget. 6:25226–25239. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ueki T, Park JH, Nishidate T, Kijima K,
Hirata K, Nakamura Y and Katagiri T: Ubiquitination and
downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T
overexpression in human breast cancer cells. Cancer Res.
69:8752–8760. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu S and Yu L: Targeting cullin-RING
ligases for cancer treatment: Rationales, advances and therapeutic
implications. Cytotechnology. 68:1–8. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jia L, Soengas MS and Sun Y: ROC1/RBX1 E3
ubiquitin ligase silencing suppresses tumor cell growth via
sequential induction of G2-M arrest, apoptosis, and senescence.
Cancer Res. 69:4974–4982. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhou L, Zhang W, Sun Y and Jia L: Protein
neddylation and its alterations in human cancers for targeted
therapy. Cell Signal. 44:92–102. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang W, Liang Y, Li L, Wang X, Yan Z,
Dong C, Zeng MS, Zhong Q, Liu XK, Yu J, et al: The nedd8-activating
enzyme inhibitor MLN4924 (TAK-924/Pevonedistat) induces apoptosis
via c-myc-noxa axis in head and neck squamous cell carcinoma. Cell
Prolif. 52:e125362019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Seifi-Alan M, Shams R, Bandehpour M,
Mirfakhraie R and Ghafouri-Fard S: Neuropilin-1 expression is
associated with lymph node metastasis in breast cancer tissues.
Cancer Manag Res. 10:1969–1974. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hosoya N and Miyagawa K: Targeting DNA
damage response in cancer therapy. Cancer Sci. 105:370–388. 2018.
View Article : Google Scholar
|
|
38
|
Affar EB, Germain M, Winstall E,
Vodenicharov M, Shah RG, Salvesen GS and Poirier GG:
Caspase-3-mediated processing of poly(ADP-ribose) glycohydrolase
during apoptosis. J Biol Chem. 276:2935–2942. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pistritto G, Trisciuoglio D, Ceci C,
Garufi A and D'Orazi G: Apoptosis as anticancer mechanism: Function
and dysfunction of its modulators and targeted therapeutic
strategies. Aging (Albany NY). 8:603–619. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chin L, Artandi SE, Shen Q, Tam A, Lee SL,
Gottlieb GJ, Greider CW and DePinho RA: P53 deficiency rescues the
adverse effects of telomere loss and cooperates with telomere
dysfunction to accelerate carcinogenesis. Cell. 97:527–538. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Titen SW and Golic KG: Telomere loss
provokes multiple pathways to apoptosis and produces genomic
instability in Drosophila melanogaster. Genetics. 180:1821–1832.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kee Y, Huang M, Chang S, Moreau LA, Park
E, Smith PG and D'Andrea AD: Inhibition of the nedd8 system
sensitizes cells to DNA interstrand cross-linking agents. Mol
Cancer Res. 10:369–377. 2012. View Article : Google Scholar : PubMed/NCBI
|
